Tower Research Capital LLC (Trc) I Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $2,844 - $5,688	-12,366 Reduced 48.68%	13,036 $3,000
Q1 2022 May 12, 2022	BUY	$0.3 - $0.61 $2,602 - $5,292	8,676 Added 51.87%	25,402 $11,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $5,778 - $10,927	10,507 Added 168.95%	16,726 $9,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $9,405 - $13,486	-8,873 Reduced 58.79%	6,219 $6,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $21,939 - $29,671	-17,983 Reduced 54.37%	15,092 $22,000
Q1 2021 May 17, 2021	SELL	$1.18 - $2.62 $2,767 - $6,143	-2,345 Reduced 6.62%	33,075 $51,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.24 $16,517 - $35,237	-15,731 Reduced 30.75%	35,420 $37,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $82,909 - $312,615	48,770 Added 2048.3%	51,151 $104,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $2,071 - $5,857	2,381 New	2,381 $5,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.